Edmund J. Moran

1.8k total citations
32 papers, 1.4k citations indexed

About

Edmund J. Moran is a scholar working on Organic Chemistry, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Edmund J. Moran has authored 32 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Organic Chemistry, 13 papers in Molecular Biology and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Edmund J. Moran's work include Inhalation and Respiratory Drug Delivery (10 papers), Asthma and respiratory diseases (10 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (9 papers). Edmund J. Moran is often cited by papers focused on Inhalation and Respiratory Drug Delivery (10 papers), Asthma and respiratory diseases (10 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (9 papers). Edmund J. Moran collaborates with scholars based in United States, United Kingdom and Canada. Edmund J. Moran's co-authors include Robert W. Armstrong, Adnan M.M. Mjalli, Peter G. Schultz, Sara Cherry, Charles Y. Cho, Sepehr Sarshar, Jeffrey Jacobs, Stephen P. A. Fodor, James C. Stephans and Cynthia L. Adams and has published in prestigious journals such as Science, Journal of the American Chemical Society and SHILAP Revista de lepidopterología.

In The Last Decade

Edmund J. Moran

32 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edmund J. Moran United States 21 775 699 186 161 139 32 1.4k
Santosh Rudrawar Australia 21 557 0.7× 986 1.4× 85 0.5× 49 0.3× 109 0.8× 54 1.6k
Marina I. Nelen United States 17 488 0.6× 472 0.7× 95 0.5× 120 0.7× 32 0.2× 27 1.2k
Daniela Perrone Italy 27 957 1.2× 824 1.2× 156 0.8× 57 0.4× 33 0.2× 75 1.6k
Utpal Ghosh India 20 483 0.6× 174 0.2× 323 1.7× 68 0.4× 92 0.7× 46 950
Yangfeng Li China 24 879 1.1× 435 0.6× 84 0.5× 26 0.2× 219 1.6× 70 1.7k
Diane M. Coe United Kingdom 27 855 1.1× 1.5k 2.2× 87 0.5× 32 0.2× 40 0.3× 60 2.0k
Stefano Guglielmo Italy 20 238 0.3× 356 0.5× 158 0.8× 47 0.3× 109 0.8× 45 868
Jaroslav Roh Czechia 23 488 0.6× 810 1.2× 113 0.6× 62 0.4× 23 0.2× 61 1.5k
Gavin A. Whitlock United Kingdom 21 452 0.6× 622 0.9× 112 0.6× 21 0.1× 36 0.3× 40 1.2k
Taha Rezai United States 11 1.1k 1.5× 351 0.5× 191 1.0× 31 0.2× 28 0.2× 12 1.4k

Countries citing papers authored by Edmund J. Moran

Since Specialization
Citations

This map shows the geographic impact of Edmund J. Moran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edmund J. Moran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edmund J. Moran more than expected).

Fields of papers citing papers by Edmund J. Moran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edmund J. Moran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edmund J. Moran. The network helps show where Edmund J. Moran may publish in the future.

Co-authorship network of co-authors of Edmund J. Moran

This figure shows the co-authorship network connecting the top 25 collaborators of Edmund J. Moran. A scholar is included among the top collaborators of Edmund J. Moran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edmund J. Moran. Edmund J. Moran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Belperio, John A., Tuan S. Nguyen, David A. Lombardi, et al.. (2023). Efficacy and safety of an inhaled pan-Janus kinase inhibitor, nezulcitinib, in hospitalised patients with COVID-19: results from a phase 2 clinical trial. BMJ Open Respiratory Research. 10(1). e001627–e001627. 5 indexed citations
2.
Siler, Thomas M., Edmund J. Moran, Chris N. Barnes, & Glenn Crater. (2020). Safety and Efficacy of Revefenacin and Formoterol in Sequence and Combination via a Standard Jet Nebulizer in Patients with Chronic Obstructive Pulmonary Disease: A Phase 3b, Randomized, 42-Day Study. Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation. 7(2). 99–106. 8 indexed citations
3.
4.
5.
Mahler, Donald A., et al.. (2019). Nebulized Versus Dry Powder Long-Acting Muscarinic Antagonist Bronchodilators in Patients With COPD and Suboptimal Peak Inspiratory Flow Rate. Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation. 6(4). 321–331. 29 indexed citations
6.
Ferguson, Gary T., Gregory Feldman, Chris N. Barnes, et al.. (2019). Improvements in Lung Function with Nebulized Revefenacin in the Treatment of Patients with Moderate to Very Severe COPD: Results from Two Replicate Phase III Clinical Trials. Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation. 6(2). 154–165. 23 indexed citations
7.
Donohue, James F., Edward Kerwin, Sanjay Sethi, et al.. (2019). Data on the safety and tolerability of revefenacin, in patients with moderate to very severe chronic obstructive pulmonary disease. SHILAP Revista de lepidopterología. 26. 104277–104277. 1 indexed citations
8.
9.
Klein, Uwe, Martin S. Linsell, Edmund J. Moran, et al.. (2014). Discovery of TD-4306, a long-acting β2-agonist for the treatment of asthma and COPD. Bioorganic & Medicinal Chemistry Letters. 24(13). 2871–2876. 10 indexed citations
10.
Jacobsen, John R., James B. Aggen, Uwe Klein, et al.. (2014). Multivalent design of long-acting β2-adrenoceptor agonists incorporating biarylamines. Bioorganic & Medicinal Chemistry Letters. 24(12). 2625–2630. 7 indexed citations
11.
Long, Daniel D., James B. Aggen, Jason Chinn, et al.. (2008). Exploring the Positional Attachment of Glycopeptide/β-lactam Heterodimers. The Journal of Antibiotics. 61(10). 603–614. 36 indexed citations
12.
Long, Daniel D., James B. Aggen, B. G. CHRISTENSEN, et al.. (2008). A Multivalent Approach to Drug Discovery for Novel Antibiotics. The Journal of Antibiotics. 61(10). 595–602. 35 indexed citations
13.
Zhang, Chengzhi, Sepehr Sarshar, Edmund J. Moran, et al.. (2001). ChemInform Abstract: 2,4,5‐Trisubstituted Imidazoles: Novel Nontoxic Modulators of P‐Glycoprotein Mediated Multidrug Resistance. Part 2.. ChemInform. 32(14). 3 indexed citations
14.
Zhang, Chengzhi, Sepehr Sarshar, Edmund J. Moran, et al.. (2000). 2,4,5-Trisubstituted imidazoles. Bioorganic & Medicinal Chemistry Letters. 10(23). 2603–2605. 53 indexed citations
15.
Sarshar, Sepehr, Chengzhi Zhang, Edmund J. Moran, et al.. (2000). 2,4,5-Trisubstituted imidazoles. Bioorganic & Medicinal Chemistry Letters. 10(23). 2599–2601. 37 indexed citations
16.
Zhang, Chengzhi, et al.. (1996). Synthesis of tetrasubstituted imidazoles via α-(N-acyl-N-alkylamino)-β-ketoamides on Wang resin. Tetrahedron Letters. 37(6). 751–754. 121 indexed citations
17.
Moran, Edmund J., Troy E. Wilson, Charles Y. Cho, Sara Cherry, & Peter G. Schultz. (1995). Novel biopolymers for drug discovery. Biopolymers. 37(3). 213–219. 49 indexed citations
18.
Cho, Charles Y., Edmund J. Moran, Sara Cherry, et al.. (1993). An Unnatural Biopolymer. Science. 261(5126). 1303–1305. 300 indexed citations
19.
Armstrong, Robert W., John E. Tellew, & Edmund J. Moran. (1992). Stereoselective synthesis of (E)- and (Z)-1-azabicyclo[3.1.0]hex-2-ylidene dehydroamino acid derivatives. The Journal of Organic Chemistry. 57(8). 2208–2211. 35 indexed citations
20.
Moran, Edmund J., et al.. (1990). Synthetic studies towards carzinophilin: Synthesis and ammonium hydroxide-induced rearrangement of the epoxi-acid fragment. Tetrahedron Letters. 31(19). 2669–2672. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Santosh Rudrawar Breakdown of academic impact, for papers by Marina I. Nelen Breakdown of academic impact, for papers by Daniela Perrone Breakdown of academic impact, for papers by Utpal Ghosh Breakdown of academic impact, for papers by Yangfeng Li Breakdown of academic impact, for papers by Diane M. Coe Breakdown of academic impact, for papers by Stefano Guglielmo Breakdown of academic impact, for papers by Jaroslav Roh Breakdown of academic impact, for papers by Gavin A. Whitlock Breakdown of academic impact, for papers by Taha Rezai
Rankless by CCL
2026